Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia - PubMed (original) (raw)
Growth hormone, cortisol, or both are involved in defense against, but are not critical to recovery from, hypoglycemia
P J Boyle et al. Am J Physiol. 1991 Mar.
Abstract
We tested the hypotheses that growth hormone, cortisol, or both are involved in defense against but are not critical to recovery from prolonged hypoglycemia and that the putative roles of these hormones in defense against prolonged hypoglycemia are permissive rather than direct. To do so we studied control subjects (n = 10) and patients with growth hormone and cortisol deficiencies resulting from hypopituitarism both in the untreated state (n = 7) and with prestudy and basal intrastudy growth hormone and cortisol replacement (n = 6). Postabsorptive plasma glucose, insulin, glucagon, and epinephrine concentrations were no different in the untreated patients and controls. Twelve-hour insulin infusions, in low doses adjusted over the 1st 2 h to produce plasma glucose concentrations of 3.6 mmol/l (65 mg/dl) and then fixed at that dose, resulted in significantly (P less than 0.0001) lower late plasma glucose concentrations in the patients, without and with replacement. The 12-h plasma glucose concentrations were 2.9 +/- 0.1 mmol/l (53 +/- 1 mg/dl) in the control subjects, 2.4 +/- 0.1 mmol/l (43 +/- 2 mg/dl; P less than 0.001 vs. control) in the deficient patients, and 2.5 +/- 0.1 mmol/l (45 +/- 2 mg/dl; P less than 0.01 vs. control) in the replaced patients. Rates of glucose recovery from hypoglycemia after discontinuation of insulin were identical in all three studies. Thus growth hormone, cortisol, or probably both play a demonstrable role in defense against prolonged, in contrast to short-term, hypoglycemia in humans. This does not appear to be the result of permissive actions of the hormones and is therefore best attributed to their increments during hypoglycemia.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
- Glucoregulation during exercise: hypoglycemia is prevented by redundant glucoregulatory systems, sympathochromaffin activation, and changes in islet hormone secretion.
Hoelzer DR, Dalsky GP, Clutter WE, Shah SD, Holloszy JO, Cryer PE. Hoelzer DR, et al. J Clin Invest. 1986 Jan;77(1):212-21. doi: 10.1172/JCI112279. J Clin Invest. 1986. PMID: 3511090 Free PMC article. Retracted. - Glucagon, not insulin, may play a secondary role in defense against hypoglycemia during exercise.
Tuttle KR, Marker JC, Dalsky GP, Schwartz NS, Shah SD, Clutter WE, Holloszy JO, Cryer PE. Tuttle KR, et al. Am J Physiol. 1988 Jun;254(6 Pt 1):E713-9. doi: 10.1152/ajpendo.1988.254.6.E713. Am J Physiol. 1988. PMID: 3287952 - Insulin and glucagon in prevention of hypoglycemia during exercise in humans.
Hirsch IB, Marker JC, Smith LJ, Spina RJ, Parvin CA, Holloszy JO, Cryer PE. Hirsch IB, et al. Am J Physiol. 1991 May;260(5 Pt 1):E695-704. doi: 10.1152/ajpendo.1991.260.5.E695. Am J Physiol. 1991. PMID: 2035626 - Nocturnal blood glucose control in type I diabetes mellitus.
Bolli GB, Perriello G, Fanelli CG, De Feo P. Bolli GB, et al. Diabetes Care. 1993 Dec;16 Suppl 3:71-89. doi: 10.2337/diacare.16.3.71. Diabetes Care. 1993. PMID: 8299480 Review. - Glucose counterregulation: prevention and correction of hypoglycemia in humans.
Cryer PE. Cryer PE. Am J Physiol. 1993 Feb;264(2 Pt 1):E149-55. doi: 10.1152/ajpendo.1993.264.2.E149. Am J Physiol. 1993. PMID: 8447379 Review.
Cited by
- Glucose counterregulatory responses to hypoglycemia.
Sprague JE, Arbeláez AM. Sprague JE, et al. Pediatr Endocrinol Rev. 2011 Sep;9(1):463-73; quiz 474-5. Pediatr Endocrinol Rev. 2011. PMID: 22783644 Free PMC article. Review. - Hypoglycaemia in elderly patients with diabetes mellitus: causes and strategies for prevention.
Chelliah A, Burge MR. Chelliah A, et al. Drugs Aging. 2004;21(8):511-30. doi: 10.2165/00002512-200421080-00003. Drugs Aging. 2004. PMID: 15182216 Review. - Hypoglycemia Unawareness-A Review on Pathophysiology and Clinical Implications.
Hölzen L, Schultes B, Meyhöfer SM, Meyhöfer S. Hölzen L, et al. Biomedicines. 2024 Feb 8;12(2):391. doi: 10.3390/biomedicines12020391. Biomedicines. 2024. PMID: 38397994 Free PMC article. Review. - Characterization of the insulin-antagonistic effect of growth hormone in man.
Fowelin J, Attvall S, von Schenck H, Smith U, Lager I. Fowelin J, et al. Diabetologia. 1991 Jul;34(7):500-6. doi: 10.1007/BF00403286. Diabetologia. 1991. PMID: 1916055 - Impaired Cortisol and Growth Hormone Counterregulatory Responses among Severe Hypoglycemic Patients with Type 2 Diabetes Mellitus.
Rhyu YA, Jang JY, Park S, An JH, Kim DL, Kim SK, Song KH. Rhyu YA, et al. Endocrinol Metab (Seoul). 2019 Jun;34(2):187-194. doi: 10.3803/EnM.2019.34.2.187. Endocrinol Metab (Seoul). 2019. PMID: 31257746 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical